Mark A Fletcher

6PUBLICATIONS
32CO-AUTHORS
Disease surveillanceMedical infection agents (incl. prions)Major global burdens of diseasePhysical education and development curriculum and pedagogyNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 27, 2025
Respiratory Syncytial Virus Infection in Older Adults in Asia: A Modified Delphi Expert Consensus on Surveillance, Diagnosis, and Prevention.

Yu-Jiun Chan, Philip Eng, Pin-Kuei Fu

|Apr 26, 2025
Correction: Méroc et al. Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine. Microorganisms 2023, 11, 1816.

Estelle Méroc, Mark A Fletcher, Germaine Hanquet

|Jul 29, 2023
Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine.

Estelle Méroc, Mark A Fletcher, Germaine Hanquet

|May 28, 2022
Correction: Theilacker et al. PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). Microorganisms 2022, 10, 127.

Christian Theilacker, Mark A Fletcher, Luis Jodar

|Jun 10, 2020
Diabetes mellitus as a vaccine-effect modifier: a review.

Thomas Verstraeten, Mark A Fletcher, Jose A Suaya

Pageof 1

Frequent Collaborators

2 joint publications

Kyla Hayford

2 joint publications

Lindsay R Grant

2 joint publications

Marc Baay

2 joint publications

Mary P E Slack